NCAM1 and non-small cell lung carcinoma: The statistical analysis showed that 81% of cases (34/42) were positive staining for NCAM1, 59.5% of cases (25/42) were positive staining for NSE, and 52.4% of cases (22/42) were positive for both NCAM1 and NSE in menin-low NSCLC samples (Fig. 6c).